期刊
CLINICAL RHEUMATOLOGY
卷 27, 期 12, 页码 1569-1571出版社
SPRINGER LONDON LTD
DOI: 10.1007/s10067-008-0979-9
关键词
Abatacept; Biologics; Pulmonary adverse events; Respiratory infections
类别
Abatacept is a biologic agent used in the treatment of rheumatoid arthritis, for which underlying chronic obstructive lung disease is listed as a precaution to its use due to concern for increased risk of respiratory adverse events. We describe two cases of severe respiratory complications affecting rheumatoid arthritis patients undergoing treatment with abatacept who had been previously diagnosed with underlying lung disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据